为您找到相关结果约500个

你是不是要搜索 期刊CD20xCD3双特异性抗体Mosunetuzumab 点击跳转

Complications in Patients with Relapsed or Refractory (R/R) Non-Hodgkin's Lymphoma (NHL) Treated with the Anti-CD20xCD3Bispecific Antibody (BsAb) Mosunetuzumab

Mosunetuzumab: First Approval

FIRST MEASUREMENT OF THE Cd-116(Ne-20, O-20)Sn-116 REACTION AT 15 A MeV

Influence of cadmium on Ru/xCd/Al2O3 catalyst for benzene partial hydrogenation

H/F substituted perovskite compounds with above-room-temperature ferroelasticity: [(CH3)(4)P][Cd(SCN)(3)] and [(CH3)(3)PCH2F][Cd(SCN)(3)]

Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting

Unusual Case of CD30-positive Lymphoma with Coexpression of CD 20

Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: a systematic review and meta-analysis

Mosunetuzumab, the First Bispecific Approved for Follicular Lymphoma

Conversion of 12-membered D-3- and L-3-(Co3Cd3II)-Cd-III metallorings into a 24-membered D3L3-(Co6Cd6II)-Cd-III metalloring

Cd-Doped Triple-Cation Perovskite Thin Films with a 20 mu s Carrier Lifetime

Experimental challenges for the measurement of the Cd-116(Ne-20,O-20)Sn-116 double charge exchange reaction

The Unconventional Cadmium Borosulfates Cd[B2O(SO4)(3)] and Cd-4[B2O(SO4)(6)]

Cd-3 and Cd-4 clusters in the rare earth (RE) metal-rich phases RE10OsCd3 and RE4OsCd

Optical Properties of Cd-Alloyed CsPbBr(3 )Nanorods

为您找到相关结果约500个

共500条页码: 1/34页15条/页